Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Thorpe Philip E"'
Autor:
Hittelman Walter N, Cheung Lawrence H, Kim Sehoon, Xu Jing, Ramdas Latha, Gomez-Manzano Candelaria, Ran Sophia, Mohamedali Khalid A, Zhang Wei, Waltenberger Johannes, Thorpe Philip E, Rosenblum Michael G
Publikováno v:
BMC Cancer, Vol 11, Iss 1, p 358 (2011)
Abstract Background The fusion protein VEGF121/rGel composed of the growth factor VEGF121 and the plant toxin gelonin targets the tumor neovasculature and exerts impressive anti-vascular effects. We have previously shown that VEGF121/rGel is cytotoxi
Externí odkaz:
https://doaj.org/article/201d501446534512a99c2b196fbfbcb0
Autor:
Huang, Xianming, Molema, Grietje, King, Steven, Watkins, Linda, Edgington, Thomas S., Thorpe, Philip E.
Publikováno v:
Science, 1997 Jan . 275(5299), 547-550.
Externí odkaz:
https://www.jstor.org/stable/2891810
Autor:
Ran, Sophia *, ∗, Thorpe, Philip E ∗
Publikováno v:
In International Journal of Radiation Oncology, Biology, Physics 1 December 2002 54(5):1479-1484
Autor:
Marquardt, John, Begent, Richard H.J., Chester, Kerry, Huston, James S., Bradbury, Andrew, Scott, Jamie K., Thorpe, Philip E., Veldman, Trudi, Reichert, Janice M., Weiner, Louis M.
Publikováno v:
mAbs
Now in its 23rd and 10th years, respectively, the Antibody Engineering and Antibody Therapeutics conferences are the Annual Meeting of The Antibody Society. The scientific program covers the full spectrum of challenges in antibody research and develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e317ac7920e121aac7f340c511ae4286
http://europepmc.org/articles/PMC3502231
http://europepmc.org/articles/PMC3502231
Autor:
Gerber, David E, Hao, Guiyang, Watkins, Linda, Stafford, Jason H, Anderson, Jon, Holbein, Blair, Öz, Orhan K, Mathews, Dana, Thorpe, Philip E, Hassan, Gedaa, Kumar, Amit, Brekken, Rolf A, Sun, Xiankai
Bavituximab is a chimeric monoclonal antibody with immune modulating and tumor-associated vascular disrupting properties demonstrated in models of non-small cell lung cancer (NSCLC). The molecular target of Bavituximab, phosphatidylserine (PS), is ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::abbc7becd1a36720ba3c0866d7e812b5
https://europepmc.org/articles/PMC4620176/
https://europepmc.org/articles/PMC4620176/
Autor:
Thorpe, Philip E.1,2,3,4,5, Detre, Simone I.1,2,3,4,5, Foxwell, Brian M. J.1,2,3,4,5, Brown, Alex N. F.1,2,3,4,5, Skilleter, David N.1,2,3,4,5, Wilson, Glynn1,2,3,4,5, Forrester, J. Anthony1,2,3,4,5, Stirpe, Fiorenzo1,2,3,4,5
Publikováno v:
European Journal of Biochemistry. 2/15/85, Vol. 147 Issue 1, p197-206. 10p.
Autor:
Thorpe, Philip E.1, Ross, Walter C. J.2,3, Brown, Alex N. F.1, Myers, Christopher D.1, Cumber, Alan J.2,3, Foxwell, Brian M. J.1, Forrester, J. Tony2,3
Publikováno v:
European Journal of Biochemistry. 4/2/84, Vol. 140 Issue 1, p63-71. 9p. 1 Diagram, 7 Graphs.
Autor:
Thorpe, Philip E.1, Brown, Alexander N.F.1, Ross, Walter C.J.1, Cumber, Alan J.1, Detre, Simone I.1, Edwards, D. Caird1, Davies, Anthony J.S.1, Stirpe, Fiorenzo1
Publikováno v:
European Journal of Biochemistry. 6/1/81, Vol. 116 Issue 3, p447-454. 8p.
Autor:
Ross, Walter C. J.1, Thorpe, Philip E.1, Cumber, Alan J.1, Edwards, D. Caird1, Hinson, Christopher A.1, Davies, Anthony J. S.1
Publikováno v:
European Journal of Biochemistry. 3/3/80, Vol. 104 Issue 2, p381-390. 10p.